Zobrazeno 1 - 7
of 7
pro vyhledávání: '"S C, Reingold"'
Autor:
F D, Lublin, S C, Reingold
Publikováno v:
Annals of neurology. 49(5)
The availability of partially effective therapies for some forms of multiple sclerosis (MS) raises practical and ethical issues for future placebo-controlled clinical trials. An international Task Force of clinicians, statisticians, ethicists and reg
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 5(4)
Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms. Traditional clinical scales such as the EDSS are inadequate in their assessment of key clinical dimensions of MS (e.g. ,
Publikováno v:
Science (New York, N.Y.). 283(5406)
Autor:
F D, Lublin, S C, Reingold
Publikováno v:
Neurology. 48(3)
Autor:
F D, Lublin, S C, Reingold
Publikováno v:
Neurology. 46(4)
Standardization of terminology used to describe the pattern and course of MS is essential for mutual understanding between clinicians and investigators. It is particularly important in design of, and recruitment for, clinical trials statistically pow
Autor:
D H, Miller, P S, Albert, F, Barkhof, G, Francis, J A, Frank, S, Hodgkinson, F D, Lublin, D W, Paty, S C, Reingold, J, Simon
Publikováno v:
Annals of neurology. 39(1)
Because of the major difficulties in measuring clinical end points in multiple sclerosis (MS) treatment trials, there has been much enthusiasm for using magnetic resonance imaging (MRI) findings as an alternative outcome. To provide international con
Autor:
D. W. Anderson, J. H. Ellenberg, C. M. Leventhal, S. C. Reingold, M. Rodriguez, D. H. Silberberg
Publikováno v:
Annals of Neurology. 32:718-719